Ország: Egyesült Királyság
Nyelv: angol
Forrás: MHRA (Medicines & Healthcare Products Regulatory Agency)
Calcitriol
Mawdsley-Brooks & Company Ltd
D05AX03
Calcitriol
3microgram/1gram
Cutaneous ointment
Cutaneous
No Controlled Drug Status
Valid as a prescribable product
BNF: 13050200
O I N T M E N T C A L C I T R I O L 3 M I C RO G R A M S / G READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. IN THIS LEAFLET: 1. What SILKIS is and what it is used for 2. What you need to know before you use SILKIS 3. How to use SILKIS 4. Possible side effects 5. How to store SILKIS 6. Contents of the pack and other information 1. WHAT SILKIS IS AND WHAT IT IS USED FOR SILKIS is used for the topical treatment of mild to moderately severe plaque psoriasis with up to one third of body surface area involvement. It contains an active ingredient, calcitriol (a vitamin D derivate), which inhibits and normalizes the unrestrained cell growth in psoriasis affected skin. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE SILKIS DO NOT USE SILKIS: • if you are treated by systemic (oral) route for a calcium deficiency • if you have a kidney or liver disease • if you have high blood calcium levels or if you suffer from abnormal calcium metabolism • if you are hypersensitive (allergic) to calcitriol or to any of the other ingredients of Silkis WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before using Silkis. • Carefully apply the ointment to the face, since it has a greater risk of irritation. Avoid contact with the eyes. • After using the ointment, wash your hands to prevent unintentional spread to non-affected zones. • Due to a potential effect on calcium metabolism, the ointment may not be applied under an occlusive wound dressing. • In case of severe irritation or hypersensitive reaction occur, the treatment should be Olvassa el a teljes dokumentumot
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Silkis 3 micrograms per g ointment 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One gram of ointment contains 3 micrograms of calcitriol (INN). For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Ointment White, translucent ointment 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Silkis is indicated in topical treatment of mild to moderately severe plaque psoriasis (psoriasis vulgaris) with up to 35% of body surface area involvement. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Silkis Ointment should be applied to the psoriasis affected areas twice per day, once in the morning and once in the evening before retiring and after washing. It is recommended that not more than 35% of the body surface be exposed to daily treatment. Not more than 30 g of ointment should be used per day. There is limited clinical experience available for the use of this dosage regimen of more than 6 weeks. _Paediatric population _ The safety and efficacy of Silkis in children less than 18 years have not been established. Currently available data are described in sections 4.4, 5.1 and 5.3 but no recommendation on a posology can be made. _Special population _ Patients with kidney or liver dysfunction should not use Silkis (see also 4.3. Contraindications). 4.3 CONTRAINDICATIONS • Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1. • Patients with kidney or liver dysfunction. • Patients with hypercalcaemia and patients known to suffer from abnormal calcium metabolism. • Patients with known hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE The ointment can be applied to the face with caution, as there is an increased risk of irritation in this area. Contact with the eyes should be avoided. The hands should be washed after applying the ointment in order to avoid unintentional application to non lesional areas. Not more than 35% of the bod Olvassa el a teljes dokumentumot